Clinical Trial

Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK)

Study acronym: PEAK-SEEK
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated August 5, 2025 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this pragmatic, decentralized, pre-consented, event-driven, randomized controlled trial is to investigate the efficacy of add-on ketamine to second-dose midazolam for prehospital treatment of epileptic children with convulsive status epilepticus.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-29.
Status change: Not Yet Recruiting → Recruiting 2025-08-03
Trial Details
NCT Number NCT07095842
Lead Sponsor Sohag University
Conditions Convulsive Status EPILEPTICUS
Enrollment 668 participants
Start Date 2025-08-03
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-05